| For: | Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. World J Gastroenterol 2016; 22(24): 5505-5511 [PMID: 27350728 DOI: 10.3748/wjg.v22.i24.5505] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i24/5505.htm |
| Number | Citing Articles |
| 1 |
Yuyuan Hu, Yuhang Yang, Yan Li, Qiang Zhang, Wei Zhang, Jinghan Jia, Zhuoyi Han, Jinxi Wang. Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1651063
|
| 2 |
Justin J. J. van der Hooft, Robert J. Goldstone, Susan Harris, Karl E. V. Burgess, David G. E. Smith. Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of Escherichia coli. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.00252
|
| 3 |
Stefan Borgmann, Beate Rieß, David Meintrup, Ingo Klare, Guido Werner. Long-Lasting Decrease of the Acquisition of Enterococcus faecium and Gram-Negative Bacteria Producing Extended Spectrum Beta-Lactamase (ESBL) by Transient Application of Probiotics. International Journal of Environmental Research and Public Health 2020; 17(17) doi: 10.3390/ijerph17176100
|
| 4 |
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, Francesco Marotta. Probiotics as Live Biotherapeutics for Veterinary and Human Health, Volume 1. 2024; doi: 10.1007/978-3-031-65455-8_7
|
| 5 |
Elisabetta Bretto, Miquel Urpì-Ferreruela, Gherzon Rimer Casanova, Begoña González-Suárez. The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease. Biomedicines 2025; 13(8) doi: 10.3390/biomedicines13081807
|
| 6 |
Celeste Manfredi, Francesco P. Calace, Ferdinando Fusco, Carmelo Quattrone, Dario Giordano, Felice Crocetto, Massimiliano Creta, Marco De Sio, Davide Arcaniolo. Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial. World Journal of Urology 2021; 39(12) doi: 10.1007/s00345-021-03773-8
|
| 7 |
Yuanbo Pan, Junjie Cheng, Yang Zhu, Jianmin Zhang, Wenpei Fan, Xiaoyuan Chen. Immunological nanomaterials to combat cancer metastasis. Chemical Society Reviews 2024; 53(12) doi: 10.1039/D2CS00968D
|
| 8 |
Timothy M. Janetos, Nancy Zakaria, Debra A. Goldstein. The Microbiome and Uveitis. The American Journal of Pathology 2023; 193(11) doi: 10.1016/j.ajpath.2023.03.004
|
| 9 |
W. Vahjen, T. Cuisiniere, J. Zentek. Protective effects of indigenous Escherichia coli against a pathogenic E. coli challenge strain in pigs. Beneficial Microbes 2017; 8(5) doi: 10.3920/BM2017.0040
|
| 10 |
Soo-Young Na. Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification. The Korean Journal of Gastroenterology 2021; 77(1) doi: 10.4166/kjg.2021.012
|
| 11 |
Letizia Masi, Cristina Ciuffini, Valentina Petito, Laura Francesca Pisani, Loris Riccardo Lopetuso, Cristina Graziani, Daniela Pugliese, Lucrezia Laterza, Pierluigi Puca, Federica Di Vincenzo, Marco Pizzoferrato, Daniele Napolitano, Laura Turchini, Valeria Amatucci, Elisa Schiavoni, Giuseppe Privitera, Laura Maria Minordi, Maria Chiara Mentella, Alfredo Papa, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri. Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update. Frontiers in Gastroenterology 2022; 1 doi: 10.3389/fgstr.2022.1022530
|
| 12 |
Vanessa N. DARGENIO, Stefania CASTELLANETA, Serena PANICO, Maria E. PAPAGNI, Costantino DARGENIO, Federico SCHETTINI, Ruggiero FRANCAVILLA, Fernanda CRISTOFORI. Probiotics and gastrointestinal diseases. Minerva Pediatrics 2023; 74(6) doi: 10.23736/S2724-5276.22.07031-8
|
| 13 |
Kaitlyn E. Barrack, Sarvesh V. Surve, Ana V. de Sousa Bezerra, Caitlin E. Murphy, Shannon M. Soucy, Miguel A. Aguilar Ramos, Rebecca A. Valls, Rebekah D. Ruff, Emily P. Balskus, Julie L. Sanville, Juliette C. Madan, George A. O’Toole, Melissa M. Kendall. A genotoxin associated with colorectal cancer linked to gut dysbiosis in children with cystic fibrosis. Journal of Bacteriology 2026; doi: 10.1128/jb.00190-26
|
| 14 |
Dhiraj Prakash Dhotre, Bhagyashree Karmarkar. Metagenomics. 2025; doi: 10.1016/B978-0-323-91631-8.00011-1
|
| 15 |
Junxiang Zhang, Xiaoman Zhang, Xiaoxin Cheng, Shijin Wang, Yangxuan Lv, Xu Zheng, Guangzhen Wu. Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1620079
|
| 16 |
Jing Zhou, Xuanying Xin, Yan Wang. From intestine to liver: A review of the pathological mechanisms of ulcerative colitis-induced secondary liver injury and targeted therapies with medicinal. The Journal of Nutritional Biochemistry 2026; 155 doi: 10.1016/j.jnutbio.2026.110361
|
| 17 |
Ahmed Elbermawi, Mohamed Samir Darwish, Asmaa A. El-Awady, Ahmed A. Zaki, Longxin Qiu, Reham M. Samra. Isolation and biological activities of compounds from Rumex vesicarius L. and their use as a component of a synbiotic preparation. Food Chemistry: X 2022; 14 doi: 10.1016/j.fochx.2022.100306
|
| 18 |
Himel Mallick, Siyuan Ma, Eric A. Franzosa, Tommi Vatanen, Xochitl C. Morgan, Curtis Huttenhower. Experimental design and quantitative analysis of microbial community multiomics. Genome Biology 2017; 18(1) doi: 10.1186/s13059-017-1359-z
|
| 19 |
Asmaa Mawad, Yosra A. Helmy, Abdel-Gawad Shalkami, Dipak Kathayat, Gireesh Rajashekara. E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro. Applied Microbiology and Biotechnology 2018; 102(24) doi: 10.1007/s00253-018-9417-3
|
| 20 |
Divakar Dahiya, Poonam Singh Nigam. The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer. Microorganisms 2022; 10(3) doi: 10.3390/microorganisms10030665
|
| 21 |
Zhongyue Ren, Yan Hong, Yalan Huo, Lingling Peng, Huihui Lv, Jiahui Chen, Zhihua Wu, Cuixiang Wan. Prospects of Probiotic Adjuvant Drugs in Clinical Treatment. Nutrients 2022; 14(22) doi: 10.3390/nu14224723
|
| 22 |
Maja Šikić Pogačar, Dušanka Mičetić-Turk, Sabina Fijan. Probiotics in the Prevention and Management of Human Diseases. 2022; doi: 10.1016/B978-0-12-823733-5.00021-0
|
| 23 |
Do-Yeon Kim, So-Yeon Lee, Jae-Yun Lee, Tae Woong Whon, June-Young Lee, Che Ok Jeon, Jin-Woo Bae. Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2412376
|
| 24 |
Muhammad Ikhmal Rosali, Dinesh Prasad V. Thanga Velu, Mohd Helmy Mokhtar, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar, Adila A. Hamid. Specificity vs. Synergy Between Single-Strain and Multi-Strain Probiotics for Ulcerative Colitis Treatment: A Review of the Literature. Biomedicines 2026; 14(6) doi: 10.3390/biomedicines14061386
|
| 25 |
Rachel Golonka, Beng San Yeoh, Matam Vijay-Kumar. The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity. Journal of Innate Immunity 2019; 11(3) doi: 10.1159/000494627
|
| 26 |
Matěj Hrala, Juraj Bosák, Lenka Micenková, Jitka Křenová, Matej Lexa, Viktória Pirková, Zuzana Tomáštíková, Ivana Koláčková, David Šmajs, Johanna Björkroth.
Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both
In Vitro
and
In Vivo
Conditions
. Applied and Environmental Microbiology 2021; 87(14) doi: 10.1128/AEM.03121-20
|
| 27 |
Anna Giudice, Carolina Brescia, Domenico Morano, Giuseppe Viglietto, Francesco Luzza, Rosario Amato, Rocco Spagnuolo. Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1774790
|
| 28 |
Hong-Ying Zhao, Guo-Tao Yang, Ning-Ning Sun, Yu Kong, Yun-Feng Liu. Efficacy and safety of stellate ganglion block in chronic ulcerative colitis. World Journal of Gastroenterology 2017; 23(3): 533-539 doi: 10.3748/wjg.v23.i3.533
|
| 29 |
Natalia Ekstedt, Dominika Jamioł-Milc, Joanna Pieczyńska. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease. Nutrients 2024; 16(13) doi: 10.3390/nu16132092
|
| 30 |
Tetsuji Hori, Kazunori Matsuda, Kenji Oishi. Probiotics: A Dietary Factor to Modulate the Gut Microbiome, Host Immune System, and Gut–Brain Interaction. Microorganisms 2020; 8(9) doi: 10.3390/microorganisms8091401
|
| 31 |
Haojie Chen, Pengyu Lei, Hao Ji, Qinsi Yang, Bo Peng, Jiahui Ma, Yimeng Fang, Linkai Qu, Hua Li, Wei Wu, Libo Jin, Da Sun. Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio 2023; 18 doi: 10.1016/j.mtbio.2023.100543
|
| 32 |
Divakar Dahiya, Poonam Singh Nigam. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer. International Journal of Molecular Sciences 2023; 24(6) doi: 10.3390/ijms24065748
|
| 33 |
Harshal Sawant, Ji Bihl, Alip Borthakur. A Simplified Method for the Isolation of Extracellular Vesicles from Probiotic Bacteria and Their Characterization. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26031058
|
| 34 |
Jason R. Bush, Michelle J. Alfa. Increasing levels of Parasutterella in the gut microbiome correlate with improving low-density lipoprotein levels in healthy adults consuming resistant potato starch during a randomised trial. BMC Nutrition 2020; 6(1) doi: 10.1186/s40795-020-00398-9
|
| 35 |
Francesco Di Pierro, Alexander Bertuccioli, Mariella Saponara, Leandro Ivaldi. Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication. Minerva Gastroenterologica e Dietologica 2020; 66(2) doi: 10.23736/S1121-421X.19.02651-5
|
| 36 |
Dandan Wu, Xiaomei Li, Yanying Yu, Bingxue Gong, Xianxuan Zhou. Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917. Biotechnology Letters 2021; 43(1) doi: 10.1007/s10529-020-03019-4
|
| 37 |
Ciara Kenneally, Craig P. Murphy, Roy D. Sleator, Eamonn P. Culligan. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiological Research 2022; 259 doi: 10.1016/j.micres.2022.127010
|
| 38 |
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa, Amien Ewunetie. Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212742
|
| 39 |
Ankita Srivastava, Jaya Gupta, Sunil Kumar, Awanish Kumar. Gut biofilm forming bacteria in inflammatory bowel disease. Microbial Pathogenesis 2017; 112 doi: 10.1016/j.micpath.2017.09.041
|
| 40 |
Bianca JC van den Bosch, Marieke JH Coenen. Pharmacogenetics of Inflammatory Bowel Disease. Pharmacogenomics 2021; 22(1) doi: 10.2217/pgs-2020-0095
|
| 41 |
Alan R. Healy, Seth B. Herzon. Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective. Journal of the American Chemical Society 2017; 139(42) doi: 10.1021/jacs.7b07807
|
| 42 |
Zhiyang Feng, Elke Burgermeister, Anna Philips, Tao Zuo, Weijie Wen. The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications. Precision Clinical Medicine 2025; 8(2) doi: 10.1093/pcmedi/pbaf010
|
| 43 |
Xilun Cui, Changfeng Li, Jing Zhong, Yuanda Liu, Pengtuo Xiao, Chang Liu, Mengwei Zhao, Wei Yang. Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1523584
|
| 44 |
Shanmukha K, Vasavi Pasupuleti, Krishna Yadav, Shubhamkumar M Baviskar, Madhulika Pradhan, Lalitkumar K. Vora, Dharmendra Kumar Khatri. Natural and Biological Products Therapeutic Potential in Restoring Gut Microbiome: Mechanistic Insights and Clinical Implications. Probiotics and Antimicrobial Proteins 2026; 18(4) doi: 10.1007/s12602-025-10796-9
|
| 45 |
G. Adrienne Weiss, Thierry Hennet. Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences 2017; 74(16) doi: 10.1007/s00018-017-2509-x
|
| 46 |
Pi Westi Bondegaard, Anders Meyer Torp, Priscila Guerra, Katja Ann Kristensen, Juliane Fjelrad Christfort, Karen Angeliki Krogfelt, Line Hagner Nielsen, Kinga Zor, Anja Boisen, Martin Steen Mortensen, Martin Iain Bahl, Tine Rask Licht. Delivery of E. coli Nissle to the mouse gut by mucoadhesive microcontainers does not improve its competitive ability against strains linked to ulcerative colitis. FEMS Microbiology Letters 2023; 370 doi: 10.1093/femsle/fnad110
|
| 47 |
Francesco Strati, Georgia Lattanzi, Chiara Amoroso, Federica Facciotti. Microbiota-targeted therapies in inflammation resolution. Seminars in Immunology 2022; 59 doi: 10.1016/j.smim.2022.101599
|
| 48 |
Dilek Sivri, Betül Şeref, Melike Şare Bulut, Makbule Gezmen Karadağ. Evaluation of the Effect of Probiotic Supplementation on Intestinal Barrier Integrity and Epithelial Damage in Colitis Disease: A Systematic Review. Nutrition Reviews 2025; 83(7) doi: 10.1093/nutrit/nuae180
|
| 49 |
Ava Behrouzi, Hoora Mazaheri, Sarvenaz Falsafi, Zahra Hoseini Tavassol, Arfa Moshiri, Seyed Davar Siadat. Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. Journal of Diabetes & Metabolic Disorders 2020; 19(1) doi: 10.1007/s40200-020-00511-6
|
| 50 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1) doi: 10.1515/dmpt-2021-0150
|
| 51 |
Sanjeeva Kumar Murali, Thomas J. Mansell. Next generation probiotics: Engineering live biotherapeutics. Biotechnology Advances 2024; 72 doi: 10.1016/j.biotechadv.2024.108336
|
| 52 |
Alberto Ramírez, Andrés Bermúdez-Luque, Juan J. Román-Camacho, Francisco J. Martín-García, Jaime Moreno-García, Mine Güngörmüşler, Francisco J. Ruiz-Castilla. Exploring the future of probiotics with innovations in delivery systems and market insights. Food Bioscience 2025; 71 doi: 10.1016/j.fbio.2025.107029
|
| 53 |
Cong Xia, Yantao Cai, Shuangyi Ren, Chenglai Xia. Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1051330
|
| 54 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1) doi: 10.1515/dmpt-2021-0150
|
| 55 |
Sergio Martínez-Ruiz, Yenifer Olivo-Martínez, Cecilia Cordero, María J. Rodríguez-Lagunas, Francisco J. Pérez-Cano, Josefa Badia, Laura Baldoma. Microbiota-Derived Extracellular Vesicles as a Postbiotic Strategy to Alleviate Diarrhea and Enhance Immunity in Rotavirus-Infected Neonatal Rats. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021184
|
| 56 |
Zi-Jun Li, Ling-Jiao Yu, Ya-Xin Yang, Ying Li, Emad Beshir Ata, Yang Zhou, Rong-Rong Zhang, Yi-Bing Lian, Hong-Liang Chen, Chun-Wei Shi, Gui-Lian Yang, Hai-Bin Huang, Yan-Long Jiang, Jian-Zhong Wang, Xin Cao, Nan Wang, Yan Zeng, Wen-Tao Yang, Chun-Feng Wang. Protective Effect of Escherichia coli Nissle 1917 on Salmonella typhimurium Infection by Regulating Intestinal Flora. Microorganisms 2026; 14(5) doi: 10.3390/microorganisms14051155
|
| 57 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2). Zeitschrift für Gastroenterologie 2024; 62(05) doi: 10.1055/a-2271-0994
|
| 58 |
Gyu Man Oh, Won Moon, Kwang Il Seo, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park, Seun Ja Park. Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study. The Korean Journal of Gastroenterology 2021; 77(1) doi: 10.4166/kjg.2020.0119
|
| 59 |
Dai Ishikawa, Xiaochen Zhang, Kei Nomura, Akihito Nagahara. Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next. Inflammatory Intestinal Diseases 2025; 10(1) doi: 10.1159/000549227
|
| 60 |
Young‐Tae Park, Taejung Kim, Jungyeob Ham, Jaeyoung Choi, Hoe‐Suk Lee, Young Joo Yeon, Soo In Choi, Nayoung Kim, Yeon‐Ran Kim, Yeong‐Jae Seok. Physiological activity of E. coli engineered to produce butyric acid. Microbial Biotechnology 2022; 15(3) doi: 10.1111/1751-7915.13795
|
| 61 |
Luigi Marongiu, Heike Allgayer. Viruses in colorectal cancer. Molecular Oncology 2022; 16(7) doi: 10.1002/1878-0261.13100
|
| 62 |
Igori Balta, Eugenia Butucel, Lavinia Stef, Ioan Pet, Gratiela Gradisteanu-Pircalabioru, Carmen Chifiriuc, Ozan Gundogdu, David McCleery, Nicolae Corcionivoschi.
Anti-
Campylobacter
Probiotics: Latest Mechanistic Insights
. Foodborne Pathogens and Disease 2022; 19(10) doi: 10.1089/fpd.2022.0039
|
| 63 |
Rami Khalaf, Martina Sciberras, Pierre Ellul. The role of the fecal microbiota in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2024; 36(11) doi: 10.1097/MEG.0000000000002818
|
| 64 |
Alex Steimle, Sarah Menz, Annika Bender, Brianna Ball, Alexander N. R. Weber, Thomas Hagemann, Anna Lange, Jan K. Maerz, Raphael Parusel, Lena Michaelis, Andrea Schäfer, Hans Yao, Hanna-Christine Löw, Sina Beier, Mehari Tesfazgi Mebrhatu, Kerstin Gronbach, Samuel Wagner, David Voehringer, Martin Schaller, Birgit Fehrenbacher, Ingo B. Autenrieth, Tobias A. Oelschlaeger, Julia-Stefanie Frick, Luis Teixeira. Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains. PLOS Biology 2019; 17(6) doi: 10.1371/journal.pbio.3000334
|
| 65 |
Federica Facciotti. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases. PharmaNutrition 2022; 21 doi: 10.1016/j.phanu.2022.100303
|
| 66 |
Carina-Shianya Alvarez, Josefa Badia, Manel Bosch, Rosa Giménez, Laura Baldomà. Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01981
|
| 67 |
Carlos R Camara-Lemarroy, Luanne M Metz, V Wee Yong. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome. World Journal of Gastroenterology 2018; 24(37): 4217-4223 doi: 10.3748/wjg.v24.i37.4217
|
| 68 |
Max van ‘t Hof, Omkar S. Mohite, Jonathan M. Monk, Tilmann Weber, Bernhard O. Palsson, Morten O. A. Sommer. High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-05108-9
|
| 69 |
Alejandro Cabezas-Cruz, José de la Fuente. Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01733
|
| 70 |
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
|
| 71 |
Lara P. Munkler, Elsayed T. Mohamed, Ruben Vazquez-Uribe, Victoria Visby Nissen, Peter Rugbjerg, Andreas Worberg, John M. Woodley, Adam M. Feist, Morten O.A. Sommer. Genetic heterogeneity of engineered Escherichia coli Nissle 1917 strains during scale-up simulation. Metabolic Engineering 2024; 85 doi: 10.1016/j.ymben.2024.08.001
|
| 72 |
María-José Fábrega, Alba Rodríguez-Nogales, José Garrido-Mesa, Francesca Algieri, Josefa Badía, Rosa Giménez, Julio Gálvez, Laura Baldomà. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01274
|
| 73 |
Peng Qiu, Takatsugu Ishimoto, Lingfeng Fu, Jun Zhang, Zhenyong Zhang, Yang Liu. The Gut Microbiota in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.733992
|
| 74 |
Victoria María Pulido, Remedios Castro, Enrique Durán-Guerrero, Cristina Lasanta, Ana Belén Díaz. Alternative beverages for probiotic foods. European Food Research and Technology 2022; 248(2) doi: 10.1007/s00217-021-03904-w
|
| 75 |
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. Biomedicine & Pharmacotherapy 2023; 165 doi: 10.1016/j.biopha.2023.114893
|
| 76 |
Matthew Cheah, Reena Khanna. Pouchitis and Ileal Pouch Disorders. 2019; doi: 10.1016/B978-0-12-809402-0.00001-0
|
| 77 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición (English ed.) 2021; 68(1) doi: 10.1016/j.endien.2020.01.010
|
| 78 |
Vajagathali Mohammed, Meenakshi Shanmugaraja. E. Coli Nissle 1917 Attenuates Antibiotic Mediated Neurotoxicity Possibly Through Gut-Brain Axis in Zebrafish. Applied Biochemistry and Biotechnology 2026; 198(5) doi: 10.1007/s12010-026-05630-z
|
| 79 |
Asghar Sedaghat, Mohammad Amir Karimi Torshizi, Mohammad Reza Soleimani. Effects of Escherichia coli Nissle 1917 on immunity, blood constituents, antioxidant capacity, egg quality and performance in laying Japanese quail. Poultry Science 2025; 104(2) doi: 10.1016/j.psj.2024.104741
|
| 80 |
Hari K. Somineni, Subra Kugathasan. The Microbiome in Patients With Inflammatory Diseases. Clinical Gastroenterology and Hepatology 2019; 17(2) doi: 10.1016/j.cgh.2018.08.078
|
| 81 |
Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar. Dietary Additives and Supplements Revisited: the Fewer, the Safer for Gut and Liver Health. Current Pharmacology Reports 2019; 5(4) doi: 10.1007/s40495-019-00187-4
|
| 82 |
Matteo M. Pusceddu, Josep M. Del Bas. The role of the gut microbiota in the pathophysiology of mental and neurological disorders. Psychiatric Genetics 2020; 30(4) doi: 10.1097/YPG.0000000000000255
|
| 83 |
Mohamed S. Darwish, Wael A. Khalil, Mahmoud A. E. Hassan, Mahmoud Moussa, Noha A. Abou-Zeid, Sameh A. Abdelnour, Asmaa A. El-Awady. Exploring the Role of E. Coli Nissle 1917 Postbiotics as Antimicrobial and Antioxidant Agents for Enhancing Buffalo Sperm Quality. Probiotics and Antimicrobial Proteins 2026; doi: 10.1007/s12602-026-10932-z
|
| 84 |
Sabina Fijan, Peter Kürti, Urška Rozman, Sonja Šostar Turk. A critical assessment of microbial-based antimicrobial sanitizing of inanimate surfaces in healthcare settings. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1412269
|
| 85 |
Da Hye Kim, Jihye Park, Soochan Kim, Mi Young Yoon, Hyun Woo Ma, I.Seul Park, Mijeong Son, Ji Hyung Kim, Tae Il Kim, Won Ho Kim, Sang Sun Yoon, Seung Won Kim, Jae Hee Cheon. An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways. Free Radical Biology and Medicine 2021; 174 doi: 10.1016/j.freeradbiomed.2021.08.002
|
| 86 |
Ulrich Sonnenborn, Lesley Robertson. Escherichia colistrain Nissle 1917—from bench to bedside and back: history of a specialEscherichia colistrain with probiotic properties. FEMS Microbiology Letters 2016; 363(19) doi: 10.1093/femsle/fnw212
|
| 87 |
Qian Qu, Shu-Peng Li, Qi Dong, Hong-Liang Du, Zhi-Hua Wang, Yi-Mu Ma, Xiao-Pei Gong, Yi-Qing Ding, Jing Zhou, Jia-Yan Chen, Meng-Jie Liu, Wei-Jie Lv, Shi-Ning Guo. Transcriptome profiling Revealed the potential mechanisms of Shen Lin Bai Zhu San n-butanol extract on DSS induced Colitis in Mice and LC-MS analysis. Phytomedicine 2023; 110 doi: 10.1016/j.phymed.2023.154645
|
| 88 |
Aida Mayorgas, Isabella Dotti, Azucena Salas. Microbial Metabolites, Postbiotics, and Intestinal Epithelial Function. Molecular Nutrition & Food Research 2021; 65(5) doi: 10.1002/mnfr.202000188
|
| 89 |
Leontien Depoorter, Yvan Vandenplas. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021; 13(7) doi: 10.3390/nu13072176
|
| 90 |
Jean-Philippe Nougayrède, Camille V. Chagneau, Jean-Paul Motta, Nadège Bossuet-Greif, Marcy Belloy, Frédéric Taieb, Jean-Jacques Gratadoux, Muriel Thomas, Philippe Langella, Eric Oswald, Alfredo G. Torres. A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917. mSphere 2021; 6(4) doi: 10.1128/mSphere.00624-21
|
| 91 |
Jiaojiao Yang, Dingwei Li, Mengjiao Zhang, Gaolong Lin, Sunkuan Hu, Helin Xu. From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems. Journal of Controlled Release 2023; 361 doi: 10.1016/j.jconrel.2023.08.007
|
| 92 |
Filippo Murina, Cecilia Fochesato, Dario Recalcati, Valeria Savasi. Efficacy of Escherichia coli Nissle 1917 for the Prevention of Recurrent Urinary Tract Infections in Women: A Preliminary Controlled Prospective Study. Clinics and Practice 2026; 16(3) doi: 10.3390/clinpract16030062
|
| 93 |
Withanage Prasadini Wasana, Amal Senevirathne, Chamilani Nikapitiya, Tae-Yang Eom, Youngdeuk Lee, Jong-Soo Lee, Do-Hyung Kang, Chulhong Oh, Mahanama De Zoysa. A Novel Pseudoalteromonas xiamenensis Marine Isolate as a Potential Probiotic: Anti-Inflammatory and Innate Immune Modulatory Effects against Thermal and Pathogenic Stresses. Marine Drugs 2021; 19(12) doi: 10.3390/md19120707
|
| 94 |
Mukta Gupta, Vijay Mishra, Monica Gulati, Bhupinder Kapoor, Amrinder Kaur, Reena Gupta, Murtaza M. Tambuwala. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology 2022; 30(2) doi: 10.1007/s10787-022-00931-1
|
| 95 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición 2021; 68(1) doi: 10.1016/j.endinu.2020.01.004
|
| 96 |
Eleftheria M. Mastoridou, Fotios S. Fousekis, Xenofon M. Sakellariou, Konstantinos Mpakogiannis, Dimitrios N. Nikas, Lampros K. Michalis, Konstantinos H. Katsanos, Haralampos Milionis. The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review. Journal of Clinical Medicine 2025; 14(18) doi: 10.3390/jcm14186476
|
| 97 |
Manon Oliero, Roy Hajjar, Thibault Cuisiniere, Gabriela Fragoso, Annie Calvé, Manuela M. Santos. Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1067505
|
| 98 |
Jun Jie Wong, Foo Kiong Ho, Pei Yi Choo, Kelvin K. L. Chong, Chee Meng Benjamin Ho, Ramesh Neelakandan, Damien Keogh, Timothy Barkham, John Chen, Chuan Fa Liu, Kimberly A. Kline, Andreas Peschel. Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competition. PLOS Pathogens 2022; 18(9) doi: 10.1371/journal.ppat.1010766
|
| 99 |
Benedetta Parodi, Nicole Kerlero de Rosbo. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.718220
|
| 100 |
Jiwei Li, Mengchi Sun, Linlin Liu, Weiguang Yang, Ao Sun, Jicheng Yu, Dongchun Liu, Wutong Zhao, Maosheng Cheng, Zhonggui He, Zhen Gu, Jin Sun. Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis. Nano Letters 2023; 23(18) doi: 10.1021/acs.nanolett.3c02408
|
| 101 |
Giovanni Marasco, Angelo Bruni, Olga Maria Nardone, Loris Riccardo Lopetuso. Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey. Journal of Clinical Medicine 2024; 13(16) doi: 10.3390/jcm13164749
|
| 102 |
George Cavic, Aude M Fahrer. Tumor‐seeking bacterial missiles. Immunology & Cell Biology 2025; 103(2) doi: 10.1111/imcb.12844
|
| 103 |
Francesco Pagano, Devin H. Bemis, Rahiya Rehman, Jason M. Shapiro, Peter Belenky. Differential impacts of hemin and free iron on amoxicillin susceptibility in ex vivo gut microbial communities. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1629464
|
| 104 |
Pichet Praveschotinunt, Anna M. Duraj-Thatte, Ilia Gelfat, Franziska Bahl, David B. Chou, Neel S. Joshi. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-13336-6
|
| 105 |
Jamison P. Huddleston, James B. Thoden, Brandon J. Dopkins, Tamari Narindoshvili, Blair J. Fose, Hazel M. Holden, Frank M. Raushel. Structural and Functional Characterization of YdjI, an Aldolase of Unknown Specificity in Escherichia coli K12. Biochemistry 2019; 58(31) doi: 10.1021/acs.biochem.9b00326
|
| 106 |
Yue Pei, Huan Yi, Lingsi Chen, Xiangqin Zheng, Bo Liu. Bioengineered Escherichia coli Nissle 1917 with hematoporphyrin monomethyl ether for targeted sonodynamic therapy and immune activation in ovarian cancer. Journal of Materials Chemistry B 2026; 14(9) doi: 10.1039/D5TB02928G
|
| 107 |
Markus F. Neurath. Current and emerging therapeutic targets for IBD. Nature Reviews Gastroenterology & Hepatology 2017; 14(5) doi: 10.1038/nrgastro.2016.208
|
| 108 |
Rudolf von Bünau, Andreas Erhardt, Eduard Stange. Comment on Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021, 13, 2176. Nutrients 2022; 14(4) doi: 10.3390/nu14040724
|
| 109 |
Shuang Li, Yi-Xuan Zhang. Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Critical Reviews in Microbiology 2024; 50(3) doi: 10.1080/1040841X.2023.2202237
|
| 110 |
Hua Liu, Zhijie Chen, Qiaowen Lin, Yi Chen, Liwen Hong, Jie Zhong, Zhengwei Cai, Zhengting Wang, Wenguo Cui. A multicellular self-organized probiotic platform for oral delivery enhances intestinal colonization. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-62349-x
|
| 111 |
Parastoo TabibzadehTehrani, Mina Nazari, Pedram Rastgoo, Niloofar Seyed Bolouri, Reyhaneh HeydariKarsaf, Abtin Hadiani, Zeinab Mohsenipour. Bacterial-based drug delivery systems: A new way to combat infectious disease. Medicine in Drug Discovery 2025; 26 doi: 10.1016/j.medidd.2025.100205
|
| 112 |
Piyush Padhi, Ahmed Abdalla, Benjamin Schneider, Nick Backes, Alyssa A. Otto, Ileia J. Scheibe, Jacob P. Thomas, Gargi Khadse, Manikandan Samidurai, Alexander K. Jochmans, Amanda George, Gary Zenitsky, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Aditya Mishra, Karin Allenspach, Jonathan Mochel, Gregory J. Phillips, Anumantha G. Kanthasamy. Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson’s disease. Cell Host & Microbe 2025; 33(11) doi: 10.1016/j.chom.2025.10.005
|
| 113 |
Katelyn M. Green, Sang-Min Shin, Ramesh K. Jha, Anand Kumar. Current and emerging approaches to manage chronic inflammatory gut disorders. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1762119
|
| 114 |
Stefano Guandalini, Naire Sansotta. Probiotics and Child Gastrointestinal Health. Advances in Experimental Medicine and Biology 2019; 1125 doi: 10.1007/5584_2018_319
|
| 115 |
Alejandro Cabezas-Cruz, Thomas Pollet, Agustín Estrada-Peña, Eleonore Allain, Sarah I. Bonnet, Sara Moutailler. Ticks and Tick-Borne Pathogens. 2019; doi: 10.5772/intechopen.80511
|
| 116 |
Lea Gnatzy, George Ismailos, Maria Vertzoni, Christos Reppas. Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities. European Journal of Pharmaceutical Sciences 2023; 188 doi: 10.1016/j.ejps.2023.106510
|
| 117 |
Abhinav Sharma, Vishnu Raman, Jungwoo Lee, Neil S. Forbes. Microbial Imbalance Induces Inflammation by Promoting Salmonella Penetration through the Mucosal Barrier. ACS Infectious Diseases 2022; 8(5) doi: 10.1021/acsinfecdis.1c00530
|
| 118 |
Ling Zhao, Mingxin Zhao, Xiankun Wang, Chenxi Jia. Proteomic Analysis of Caco-2 Cells Disrupted by EcN 1917-Derived OMVs Reveals Molecular Information on Bacteria-Mediated Cancer Cell Migration. Journal of Proteome Research 2024; 23(7) doi: 10.1021/acs.jproteome.4c00176
|
| 119 |
Yenifer Olivo-Martínez, Sergio Martínez-Ruiz, Cecilia Cordero-Alday, Manel Bosch, Josefa Badia, Laura Baldoma. Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 in the Interleukin-1β-Induced Inflammation Model of Intestinal Epithelial Cells. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105338
|
| 120 |
Jiayu Ye, Lauren A. E. Erland, Sandeep K. Gill, Stephanie L. Bishop, Andrea Verdugo-Meza, Susan J. Murch, Deanna L. Gibson. Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products. Biomolecules 2021; 11(5) doi: 10.3390/biom11050738
|
| 121 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009. Zeitschrift für Gastroenterologie 2023; 61(08) doi: 10.1055/a-2060-0935
|
| 122 |
Torsten Kucharzik, Axel U. Dignass, Raja Atreya, Bernd Bokemeyer, Philip Esters, Klaus Herrlinger, Klaus Kannengießer, Peter Kienle, Jost Langhorst, Andreas Lügering, Stefan Schreiber, Andreas Stallmach, Jürgen Stein, Andreas Sturm, Niels Teich, Britta Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Zeitschrift für Gastroenterologie 2020; 58(12) doi: 10.1055/a-1296-3444
|
| 123 |
Di Nie, Yishan Lv, Duo Gao, Anqi Xu, Qinyu Li, Jiaxin Li, Xiang Lu, Bingqi Wang, Jie Wang, Chang Liu, Zhuan Zhang, Xiang Li, Ning Wang, Shiyan Guo, Chunliu Zhu, Miaorong Yu, Yong Gan. Enhanced cytosolic RNA delivery through early endosome fusion-mediated release via probiotic-derived lipopolysaccharide (LPS)-incorporated vesicles. Nano Today 2024; 59 doi: 10.1016/j.nantod.2024.102480
|
| 124 |
Hussein Sabit, Areej Kassab, Donia Alaa, Shaza Mohamed, Shaimaa Abdel-Ghany, Mohamed Mansy, Osama A. Said, Mona A. Khalifa, Halah Hafiz, Asmaa M. Abushady. The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients. Current Issues in Molecular Biology 2023; 45(5) doi: 10.3390/cimb45050260
|
| 125 |
M. Tyler Nelson, Mark R. Charbonneau, Heidi G. Coia, Mary J. Castillo, Corey Holt, Eric S. Greenwood, Peter J. Robinson, Elaine A. Merrill, David Lubkowicz, Camilla A. Mauzy. Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-23072-5
|
| 126 |
Jun Shi, DongXue Ma, ShanHu Gao, Fei Long, Xin Wang, XingYu Pu, Richard D. Cannon, Ting-Li Han. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1219763
|
| 127 |
Claudia Cappella, Chiara Redaelli, Melissa Balzarotti, Pasquale Scarcia, Gennaro Agrimi, Maurizio Bettiga.
Rethinking probiotics: breaking the
Lactobacillus
-
Bifidobacterium
duopoly in the management of dysbiosis and allergies
. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2673679
|
| 128 |
Husheem Michael, Ayako Miyazaki, Stephanie N. Langel, Joshua O. Amimo, Maryssa K. Kick, Juliet Chepngeno, Francine C. Paim, David D. Fischer, Gireesh Rajashekara, Linda J. Saif, Anastasia N. Vlasova. Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model. Vaccines 2022; 10(1) doi: 10.3390/vaccines10010083
|
| 129 |
Marco Constante, Gabriela Fragoso, Joseph Lupien-Meilleur, Annie Calvé, Manuela M. Santos. Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis. Inflammatory Bowel Diseases 2017; 23(5) doi: 10.1097/MIB.0000000000001089
|
| 130 |
Guigen Teng, Zilin Liu, Yun Liu, Ting Wu, Yun Dai, Huahong Wang, Weihong Wang. Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.819336
|
| 131 |
Peijun Yu, Wenjing Zhou, Chunyang Li, Qiang Sun, Yunpeng Yang. Construction of an engineered Escherichia coli strain with enhanced intestinal colonization and anti-inflammatory efficacy in colitis. Cellular & Molecular Immunology 2026; 23(6) doi: 10.1038/s41423-026-01415-w
|
| 132 |
Lixuan Wang, Jing Hu, Kun Li, Yuliang Zhao, Motao Zhu. Advancements in gene editing technologies for probiotic-enabled disease therapy. iScience 2024; 27(9) doi: 10.1016/j.isci.2024.110791
|
| 133 |
Otakar Dusek, Alena Fajstova, Aneta Klimova, Petra Svozilkova, Tomas Hrncir, Miloslav Kverka, Stepan Coufal, Johan Slemin, Helena Tlaskalova-Hogenova, John V. Forrester, Jarmila Heissigerova. Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917. Cells 2020; 10(1) doi: 10.3390/cells10010023
|
| 134 |
Manyu Liang, Jing Zhang, Yanhong Yang, Yi Xia, Lintao Liu, Li Liu, Qin Wang, Xiaowei Gao. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice. World Journal of Microbiology and Biotechnology 2023; 39(1) doi: 10.1007/s11274-022-03452-9
|
| 135 |
Lu Zhang, Jiahui Yang, Qixue Shi, Yanyan Chu, Jiarui Cao, Chenglong Shang, Changlin Zhou, Lingman Ma. Arginine-mediated inhibition of macrophage apoptosis by Escherichia coli nissle 1917 in Salmonella typhimurium-induced intestinal inflammation. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1684234
|
| 136 |
Kangsan Kim, Donghui Choe, Minjeong Kang, Bong Hyun Sung, Haseong Kim, Seung‐Goo Lee, Dae‐Hee Lee, Byung‐Kwan Cho. Principles in Microbiome Engineering. 2022; doi: 10.1002/9783527825462.ch3
|
| 137 |
Gitana Maria Aceto, Katia Falasca, Desirèe Berardinucci, Ludovica Cavallo, Alessio Mangiò, Giuseppe Mancuso, Raffaella Muraro, Rachele Ciccocioppo, Teresa Catalano. Deciphering the Implications of Escherichia coli in Inflammatory Bowel Disease: From Symbiont to Pathogen. Pathogens 2026; 15(5) doi: 10.3390/pathogens15050548
|
| 138 |
Manonmani Soundararajan, Rudolf von Bünau, Tobias A. Oelschlaeger. K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic E. coli Strain Nissle 1917. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02783
|
| 139 |
Atchareeya Nakkarach, Hooi Ling Foo, Adelene Ai-Lian Song, Sunee Nitisinprasert, Ulaiwan Withayagiat. Promising discovery of beneficial Escherichia coli in the human gut. 3 Biotech 2020; 10(7) doi: 10.1007/s13205-020-02289-z
|
| 140 |
Fernanda Cristofori, Vanessa Nadia Dargenio, Costantino Dargenio, Vito Leonardo Miniello, Michele Barone, Ruggiero Francavilla. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.578386
|
| 141 |
Louis C Dacquay, Derek Tsang, Donny Chan, John Parkinson, Dana J Philpott, David R McMillen. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1994832
|
| 142 |
Jiali Yang, Guizhen Zhang, Xinyuan Yang, Mengyun Peng, Shengchan Ge, Shaochong Tan, Zhiyang Wen, Yifei Wang, Sixuan Wu, Yan Liang, Jingyi An, Kaixiang Zhang, Junjie Liu, Jinjin Shi, Zhenzhong Zhang. An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment. Chemical Engineering Journal 2022; 446 doi: 10.1016/j.cej.2022.137204
|
| 143 |
Aluminé Lezcano, Emanuel Miculan, Geronimo Ducca, Carolina Ruera, María Luz Iribarren, Philippe Tixador, Xavier Roux, Fernando Gabriel Chirdo. Saccharomyces boulardii CNCM I-745 protects against small intestinal injury in a model of gliadin-peptide-induced sterile inflammatory enteropathy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1846961
|
| 144 |
Haoxiang Chen, Jingtong Wu, Qingxia Shi, Ziyi Zhang, Yongtian Zheng, Yanyun Fan, Lei Ren. Nanospatially confined ROS eliminator produced in situ by engineered Escherichia coli Nissle 1917 for oral treatment of inflammatory bowel disease. Journal of Controlled Release 2026; 394 doi: 10.1016/j.jconrel.2026.114837
|
| 145 |
Liang Dai, Yingjue Tang, Wenjun Zhou, Yanqi Dang, Qiaoli Sun, Zhipeng Tang, Mingzhe Zhu, Guang Ji. Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.620724
|
| 146 |
Yu. O. Shulpekova, V. Yu. Rusyaev. Daily probiotics: benefits and reasonable application. Meditsinskiy sovet = Medical Council 2021; (15) doi: 10.21518/2079-701X-2021-15-136-143
|
| 147 |
Ning Li, Minghui Wu, Lu Wang, Mengyu Tang, Hongbo Xin, Keyu Deng. Efficient Isolation of Outer Membrane Vesicles (OMVs) Secreted by Gram-Negative Bacteria via a Novel Gradient Filtration Method. Membranes 2024; 14(6) doi: 10.3390/membranes14060135
|
| 148 |
Piu Saha, Beng San Yeoh, Rodrigo A Olvera, Xia Xiao, Vishal Singh, Deepika Awasthi, Bhagawat C Subramanian, Qiuyan Chen, Madhu Dikshit, Yanming Wang, Carole A Parent, Matam Vijay-Kumar. Bacterial Siderophores Hijack Neutrophil Functions. The Journal of Immunology 2017; 198(11) doi: 10.4049/jimmunol.1700261
|
| 149 |
Sheng Liu, Wenjing Zhao, Ping Lan, Xiangyu Mou. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein & Cell 2021; 12(5) doi: 10.1007/s13238-020-00745-3
|
| 150 |
Yunqing Xiang, Huipai Peng, Yanxia Li, Hui Wen, Nan Li, Xiaozhi Liu, Guodong Yuan, Yong Shi, Shuqiang Huang. Cellular membrane protein MipA from E.coli Nissle 1917 protects against Salmonella infection. The ISME Journal 2026; 20(1) doi: 10.1093/ismejo/wrag054
|
| 151 |
Christian Zimmermann, Marius Schild, Clemens Kunz, Kurt Zimmermann, Sabine Kuntz. Effects of live and heat-inactivated E. coli strains and their supernatants on immune regulation in HT-29 cells. European Journal of Microbiology and Immunology 2018; 8(2) doi: 10.1556/1886.2018.00004
|
| 152 |
Maria D. Ardatskaya, Grigory V. Garushyan. Restoration of microbiota balance using spore-forming probiotic microorganisms: a review. Consilium Medicum 2026; 28(5) doi: 10.26442/20751753.2026.5.203651
|
| 153 |
Bothyna Ghanem, Randa Nayef Haddadin. Multiple drug resistance and biocide resistance in Escherichia coli environmental isolates from hospital and household settings. Antimicrobial Resistance & Infection Control 2018; 7(1) doi: 10.1186/s13756-018-0339-8
|
| 154 |
Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon. Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model. Intestinal Research 2021; 19(4) doi: 10.5217/ir.2021.00121
|
| 155 |
Caterina Foppa, Tommy Rizkala, Alessandro Repici, Cesare Hassan, Antonino Spinelli. Microbiota and IBD: Current knowledge and future perspectives. Digestive and Liver Disease 2024; 56(6) doi: 10.1016/j.dld.2023.11.015
|
| 156 |
Jun-Hwan Yoo, Mark Donowitz. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases. World Journal of Gastroenterology 2019; 25(30): 4125-4147 doi: 10.3748/wjg.v25.i30.4125
|
| 157 |
Rasmita Mishra, Smrutishree Mohanty, Soumendu Mahapatra, Punit Prasad. Microbiome Therapeutics. 2023; doi: 10.1016/B978-0-323-99336-4.00008-2
|
| 158 |
Ruth Dudek-Wicher, Adam Junka, Justyna Paleczny, Marzenna Bartoszewicz. Clinical Trials of Probiotic Strains in Selected Disease Entities. International Journal of Microbiology 2020; 2020 doi: 10.1155/2020/8854119
|
| 159 |
Junhua Xie, Qiqiong Li, Shaoping Nie. Bacterial extracellular vesicles: An emerging postbiotic. Trends in Food Science & Technology 2024; 143 doi: 10.1016/j.tifs.2023.104275
|
| 160 |
Kaisa Hiippala, Hanne Jouhten, Aki Ronkainen, Anna Hartikainen, Veera Kainulainen, Jonna Jalanka, Reetta Satokari. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018; 10(8) doi: 10.3390/nu10080988
|
| 161 |
Mingyang Hu, Xiyun Zhang, Jinze Li, Luotong Chen, Xiaolin He, Tingting Sui. Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.940196
|
| 162 |
Naga Sandhya Guntaka, Alan R. Healy, Jason M. Crawford, Seth B. Herzon, Steven D. Bruner. Structure and Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway. ACS Chemical Biology 2017; 12(10) doi: 10.1021/acschembio.7b00479
|
| 163 |
Yong-Hua Shen, Hao Zhu, Lin Zhou, Yan-Qing Zheng, Zhan Zhang, Ying Xie, Zhen-Qing Liu, Chun-Yan Peng, Lei Wang, Cheng Zhao, Xiao-Qi Zhang. In inflammatory bowel disease and extraintestinal manifestations: What role does microbiome play?. Engineered Regeneration 2023; 4(4) doi: 10.1016/j.engreg.2023.04.005
|
| 164 |
Ning Li, Hongbo Xin, Keyu Deng. Separation and Characterization of Heterogeneity Among Various Sizes of Outer Membrane Vesicles Derived from the Probiotic Escherichia coli Nissle 1917. Membranes 2025; 15(5) doi: 10.3390/membranes15050141
|
| 165 |
Alan R. Healy, Herman Nikolayevskiy, Jaymin R. Patel, Jason M. Crawford, Seth B. Herzon. A Mechanistic Model for Colibactin-Induced Genotoxicity. Journal of the American Chemical Society 2016; 138(48) doi: 10.1021/jacs.6b10354
|
| 166 |
Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020; 9(5) doi: 10.3390/cells9051234
|
| 167 |
Oliver Grundmann. Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel Disorders. EMJ Microbiology & Infectious Diseases 2020; doi: 10.33590/emjmicrobiolinfectdis/20-00050
|
| 168 |
Gozeel Binte Shahid, Recep Erdem Ahan, Julian Ostaku, Urartu Ozgur Safak Seker. Bacterial Living Therapeutics with Engineered Protein Secretion Circuits to Eliminate Breast Cancer Cells. ACS Synthetic Biology 2024; 13(10) doi: 10.1021/acssynbio.3c00723
|
| 169 |
Nathan Crook, Aura Ferreiro, Andrew J. Gasparrini, Mitchell W. Pesesky, Molly K. Gibson, Bin Wang, Xiaoqing Sun, Zevin Condiotte, Stephen Dobrowolski, Daniel Peterson, Gautam Dantas. Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut. Cell Host & Microbe 2019; 25(4) doi: 10.1016/j.chom.2019.02.005
|
| 170 |
Seockmo Ku, Suyoung Yang, Hyun Ha Lee, Deokyeong Choe, Tony V. Johnston, Geun Eog Ji, Myeong Soo Park. Biosafety assessment of Bifidobacterium animalis subsp. lactis AD011 used for human consumption as a probiotic microorganism. Food Control 2020; 117 doi: 10.1016/j.foodcont.2019.106985
|
| 171 |
Chrysoula Dimopoulou, Priscila Regina Guerra, Martin Steen Mortensen, Katja Ann Kristensen, Mikael Pedersen, Martin Iain Bahl, Morten Alexander Otto Sommer, Tine Rask Licht, Martin Frederik Laursen. Potential of using an engineered indole lactic acid producing Escherichia coli Nissle 1917 in a murine model of colitis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68412-9
|
| 172 |
Jie Gao, Xiyu Li, Guohua Zhang, Faizan Ahmed Sadiq, Jesus Simal‐Gandara, Jianbo Xiao, Yaxin Sang. Probiotics in the dairy industry—Advances and opportunities. Comprehensive Reviews in Food Science and Food Safety 2021; 20(4) doi: 10.1111/1541-4337.12755
|
| 173 |
Xing Jin, Sungjun An, Weston Kightlinger, Jiacheng Zhou, Seok Hoon Hong. Engineering Escherichia coli to produce and secrete colicins for rapid and selective biofilm cell killing. AIChE Journal 2021; 67(12) doi: 10.1002/aic.17466
|
| 174 |
Zachary J. S. Mays, Todd C. Chappell, Nikhil U. Nair. Quantifying and Engineering Mucus Adhesion of Probiotics. ACS Synthetic Biology 2020; 9(2) doi: 10.1021/acssynbio.9b00356
|
| 175 |
Yvan Vandenplas, Leontien Depoorter. Reply to von Bünau et al. Comment on “Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021, 13, 2176”. Nutrients 2022; 14(4) doi: 10.3390/nu14040725
|
| 176 |
Gopal S Palandurkar, Sunil Kumar. Biofilm's Impact on Inflammatory Bowel Diseases . Cureus 2023; doi: 10.7759/cureus.45510
|
| 177 |
Luca Falzone, Alessandro Lavoro, Saverio Candido, Mario Salmeri, Antonino Zanghì, Massimo Libra.
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing
Escherichia coli
Nissle 1917 strain
. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2397874
|